0001546927-16-000462.txt : 20160314
0001546927-16-000462.hdr.sgml : 20160314
20160314153355
ACCESSION NUMBER: 0001546927-16-000462
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160311
FILED AS OF DATE: 20160314
DATE AS OF CHANGE: 20160314
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Imprimis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001360214
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450567010
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-704-4042
MAIL ADDRESS:
STREET 1: 12264 EL CAMINO REAL
STREET 2: SUITE 350
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSDEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20070912
FORMER COMPANY:
FORMER CONFORMED NAME: Bywater Resources, Inc
DATE OF NAME CHANGE: 20060421
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Opaleye Management Inc.
CENTRAL INDEX KEY: 0001595855
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35814
FILM NUMBER: 161503666
BUSINESS ADDRESS:
STREET 1: 175 FEDERAL STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-904-9195
MAIL ADDRESS:
STREET 1: 175 FEDERAL STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
4/A
1
opaleyeimmyform4filed.xml
OWNERSHIP DOCUMENT
X0306
4/A
2016-03-11
2016-03-14
1
0001360214
Imprimis Pharmaceuticals, Inc.
IMMY
0001595855
Opaleye Management Inc.
175 FEDERAL STREET, 6TH FLOOR
BOSTON
MA
02110
0
0
1
0
Common Stock
2016-03-11
2016-03-11
4
P
0
45000
3.60
A
1250000
I
See Foonote
Securities reported herein for Opaleye Management, Inc. (the "Company) represent Common Stock beneficially owned and held of record by the Company and Opaleye, L.P., a private fund for which the Company serves as the investment manager (the "Fund"). James Silverman is the President and sole shareholder of the Company. The Company, the Fund and Mr. Silverman (the "Reporting Persons") are each beneficial owners and have an address of 175 Federal Street, 6th Floor, Boston, MA 02110. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares and warrants in which the Reporting Persons have no actual pecuniary interest therein.
James Silverman, individually
2016-03-14
James Silverman, as Manager of Opaleye GP LLC
2016-03-14
James Silverman, as President of Opaleye Management, Inc.
2016-03-14